Purpose: To assess the efficacy of low mechanical index (MI) real time grey scale contrast-enhanced US (CEUS) in the differentiation of breast lesions in comparison to Magnetic Resonance Imaging (MRI). Materials and Methods: 50 lesions previously detected at mammography or conventional US were evaluated by means of CEUS and MRI. Contrast-enhanced examinations were performed with a dedicated equipment (Esatune, Esaote, Genoa, Italy), before and after injection of 4.8 ml of Sonovue (Bracco, Milan, Italy). MRI was conducted with a 1.5 T equipment (Siemens Vision Plus, Erlangen, Germany) with bilateral dedicated superficial coil, on T2w STIR and 3D Flash T1w before and 1, 2, 3, 4, 5 minutes after the administration of contrast agent (Gd-DTPA, 1.5 ml/ Kg). Wash-in and wash out curves were assessed for both procedures. A specific sonographic quan-, tification software (Qontrast, Bracco, Milan, Italy), based off pixel by pixel signal intensity over time, was used to obtain contrast-enhanced sonographic perfusion maps for each lesion. Mc Nemar test was then calculated. Results: 24 invasive ductal carcinomas, 18 fibroadenomas, 4 fibro-cystic dysplasias, 1 mucin ous carcinoma, 1 invasive ducto-lobularcarcinoma, 1 intraductal florid papillomatosis and 1 phylloides tumour were diagnosed. Contrastenhanced sonographic patterns correlated well with those provided by MRI. Sensitivity, specificity, and accuracy of US were: 69.2%, 66.7%, and 68%, respectively. According to the different contrast enhancement patterns and the resulting perfusion maps, all the malignant lesions and 9 out of 12 benign lesions were correctly diagnosed, thus resulting in 87.5% of specificity and 100% of sensitivity. Regarding the specificity, there is no difference between US and CEUS with McNemar (p=0.18). Regarding sensitivity, the difference between contrast-enhanced US and US is significant as calculated with McNemar test (p=0.013). The three lesions which were incorrectly classified as malignant were two hypervascularised fibroadenomas in young women and a phylloides tumour. Conclusion: CEUS seems to be a reliable method to differentiate breast lesions, since it provides typical enhancement patterns. Contrast sonographic perfusion curves correlate well with MRI wash in-wash out curves.

Benign and malignant breast lesions: Efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging / Cantisani, Vito; Ballesio, Laura; Pagliara, E.; Sallusti, Elvira; Drudi, Francesco Maria; Trippa, F.; Calascibetta, F.; Erturk, S. M.; Ricci, Paolo; Modesti, Mauro; Passariello, Roberto. - In: ULTRASCHALL IN DER MEDIZIN. - ISSN 0172-4614. - STAMPA. - 28:1(2007), pp. 57-62. [10.1055/s-2006-927226]

Benign and malignant breast lesions: Efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging

CANTISANI, VITO;BALLESIO, Laura;SALLUSTI, elvira;DRUDI, Francesco Maria;RICCI, Paolo;MODESTI, Mauro;PASSARIELLO, Roberto
2007

Abstract

Purpose: To assess the efficacy of low mechanical index (MI) real time grey scale contrast-enhanced US (CEUS) in the differentiation of breast lesions in comparison to Magnetic Resonance Imaging (MRI). Materials and Methods: 50 lesions previously detected at mammography or conventional US were evaluated by means of CEUS and MRI. Contrast-enhanced examinations were performed with a dedicated equipment (Esatune, Esaote, Genoa, Italy), before and after injection of 4.8 ml of Sonovue (Bracco, Milan, Italy). MRI was conducted with a 1.5 T equipment (Siemens Vision Plus, Erlangen, Germany) with bilateral dedicated superficial coil, on T2w STIR and 3D Flash T1w before and 1, 2, 3, 4, 5 minutes after the administration of contrast agent (Gd-DTPA, 1.5 ml/ Kg). Wash-in and wash out curves were assessed for both procedures. A specific sonographic quan-, tification software (Qontrast, Bracco, Milan, Italy), based off pixel by pixel signal intensity over time, was used to obtain contrast-enhanced sonographic perfusion maps for each lesion. Mc Nemar test was then calculated. Results: 24 invasive ductal carcinomas, 18 fibroadenomas, 4 fibro-cystic dysplasias, 1 mucin ous carcinoma, 1 invasive ducto-lobularcarcinoma, 1 intraductal florid papillomatosis and 1 phylloides tumour were diagnosed. Contrastenhanced sonographic patterns correlated well with those provided by MRI. Sensitivity, specificity, and accuracy of US were: 69.2%, 66.7%, and 68%, respectively. According to the different contrast enhancement patterns and the resulting perfusion maps, all the malignant lesions and 9 out of 12 benign lesions were correctly diagnosed, thus resulting in 87.5% of specificity and 100% of sensitivity. Regarding the specificity, there is no difference between US and CEUS with McNemar (p=0.18). Regarding sensitivity, the difference between contrast-enhanced US and US is significant as calculated with McNemar test (p=0.013). The three lesions which were incorrectly classified as malignant were two hypervascularised fibroadenomas in young women and a phylloides tumour. Conclusion: CEUS seems to be a reliable method to differentiate breast lesions, since it provides typical enhancement patterns. Contrast sonographic perfusion curves correlate well with MRI wash in-wash out curves.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/903171
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 84
  • ???jsp.display-item.citation.isi??? 62
social impact